OCUGEN INC (OCGN) Fundamental Analysis & Valuation

NASDAQ:OCGN • US67577C1053

Current stock price

1.99 USD
+0.06 (+3.11%)
At close:
1.97 USD
-0.02 (-1.01%)
After Hours:

This OCGN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. OCGN Profitability Analysis

1.1 Basic Checks

  • OCGN had negative earnings in the past year.
  • In the past year OCGN has reported a negative cash flow from operations.
  • OCGN had negative earnings in each of the past 5 years.
  • OCGN had a negative operating cash flow in each of the past 5 years.
OCGN Yearly Net Income VS EBIT VS OCF VS FCFOCGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M

1.2 Ratios

  • OCGN has a worse Return On Assets (-111.15%) than 78.53% of its industry peers.
  • With a Return On Equity value of -1812.06%, OCGN is not doing good in the industry: 82.40% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -111.15%
ROE -1812.06%
ROIC N/A
ROA(3y)-106.4%
ROA(5y)-89.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OCGN Yearly ROA, ROE, ROICOCGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 1K 1.5K

1.3 Margins

  • OCGN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OCGN Yearly Profit, Operating, Gross MarginsOCGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20K -40K -60K -80K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. OCGN Health Analysis

2.1 Basic Checks

  • OCGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for OCGN has been increased compared to 1 year ago.
  • OCGN has more shares outstanding than it did 5 years ago.
  • OCGN has a worse debt/assets ratio than last year.
OCGN Yearly Shares OutstandingOCGN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
OCGN Yearly Total Debt VS Total AssetsOCGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • OCGN has an Altman-Z score of -5.22. This is a bad value and indicates that OCGN is not financially healthy and even has some risk of bankruptcy.
  • OCGN's Altman-Z score of -5.22 is on the low side compared to the rest of the industry. OCGN is outperformed by 64.99% of its industry peers.
  • A Debt/Equity ratio of 8.04 is on the high side and indicates that OCGN has dependencies on debt financing.
  • The Debt to Equity ratio of OCGN (8.04) is worse than 82.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.04
Debt/FCF N/A
Altman-Z -5.22
ROIC/WACCN/A
WACC9.1%
OCGN Yearly LT Debt VS Equity VS FCFOCGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M

2.3 Liquidity

  • OCGN has a Current Ratio of 1.85. This is a normal value and indicates that OCGN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of OCGN (1.85) is worse than 79.30% of its industry peers.
  • A Quick Ratio of 1.85 indicates that OCGN should not have too much problems paying its short term obligations.
  • OCGN's Quick ratio of 1.85 is on the low side compared to the rest of the industry. OCGN is outperformed by 77.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.85
OCGN Yearly Current Assets VS Current LiabilitesOCGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. OCGN Growth Analysis

3.1 Past

  • OCGN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.05%.
  • The Revenue has grown by 8.83% in the past year. This is quite good.
  • The Revenue has been growing by 156.17% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-21.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)8.83%
Revenue growth 3YN/A
Revenue growth 5Y156.17%
Sales Q2Q%-125.26%

3.2 Future

  • The Earnings Per Share is expected to grow by 51.18% on average over the next years. This is a very strong growth
  • OCGN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 215.00% yearly.
EPS Next Y1.17%
EPS Next 2Y5.92%
EPS Next 3Y27.37%
EPS Next 5Y51.18%
Revenue Next Year-60.02%
Revenue Next 2Y169.63%
Revenue Next 3Y216.47%
Revenue Next 5Y215.01%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OCGN Yearly Revenue VS EstimatesOCGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B
OCGN Yearly EPS VS EstimatesOCGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100

More info and screens

Find the best growth stocksShow best growing peers

1

4. OCGN Valuation Analysis

4.1 Price/Earnings Ratio

  • OCGN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OCGN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OCGN Price Earnings VS Forward Price EarningsOCGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OCGN Per share dataOCGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as OCGN's earnings are expected to grow with 27.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.92%
EPS Next 3Y27.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OCGN Dividend Analysis

5.1 Amount

  • No dividends for OCGN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OCGN Fundamentals: All Metrics, Ratios and Statistics

OCUGEN INC

NASDAQ:OCGN (4/17/2026, 8:00:02 PM)

After market: 1.97 -0.02 (-1.01%)

1.99

+0.06 (+3.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-04
Earnings (Next)05-01
Inst Owners18.84%
Inst Owner Change0.18%
Ins Owners2.3%
Ins Owner Change40.95%
Market Cap652.52M
Revenue(TTM)4.41M
Net Income(TTM)-64.02M
Analysts83.08
Price Target11.37 (471.36%)
Short Float %20.29%
Short Ratio7.9
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.9%
Min EPS beat(2)-22.55%
Max EPS beat(2)14.75%
EPS beat(4)3
Avg EPS beat(4)3.39%
Min EPS beat(4)-22.55%
Max EPS beat(4)14.75%
EPS beat(8)7
Avg EPS beat(8)15.68%
EPS beat(12)9
Avg EPS beat(12)14.24%
EPS beat(16)10
Avg EPS beat(16)-204.99%
Revenue beat(2)2
Avg Revenue beat(2)248.45%
Min Revenue beat(2)212.3%
Max Revenue beat(2)284.59%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)23.81%
PT rev (3m)23.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.33%
EPS NY rev (1m)5.57%
EPS NY rev (3m)7.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 121.51
P/FCF N/A
P/OCF N/A
P/B 184.69
P/tB 184.69
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.02
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -111.15%
ROE -1812.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-106.4%
ROA(5y)-89.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 8.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.82%
Cap/Sales 3.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.85
Altman-Z -5.22
F-Score1
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)555.94%
Cap/Depr(5y)612.44%
Cap/Sales(3y)87.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y1.17%
EPS Next 2Y5.92%
EPS Next 3Y27.37%
EPS Next 5Y51.18%
Revenue 1Y (TTM)8.83%
Revenue growth 3YN/A
Revenue growth 5Y156.17%
Sales Q2Q%-125.26%
Revenue Next Year-60.02%
Revenue Next 2Y169.63%
Revenue Next 3Y216.47%
Revenue Next 5Y215.01%
EBIT growth 1Y3.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.87%
OCF growth 3YN/A
OCF growth 5YN/A

OCUGEN INC / OCGN Fundamental Analysis FAQ

What is the fundamental rating for OCGN stock?

ChartMill assigns a fundamental rating of 2 / 10 to OCGN.


What is the valuation status for OCGN stock?

ChartMill assigns a valuation rating of 1 / 10 to OCUGEN INC (OCGN). This can be considered as Overvalued.


How profitable is OCUGEN INC (OCGN) stock?

OCUGEN INC (OCGN) has a profitability rating of 0 / 10.


What is the earnings growth outlook for OCUGEN INC?

The Earnings per Share (EPS) of OCUGEN INC (OCGN) is expected to grow by 1.17% in the next year.